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Summary A 73-year-old female underwent percutaneous coronary intervention
(PCI) because of stable angina. An elective PCI for the RCA lesion was ﬁrst per-
formed with deploying sirolimus eluting stents (SES). Three weeks later, PCI was
also provided in the residual LAD lesion. Eight months later, she presented with
new angina. CAG revealed an in-stent restenosis in the mid LAD and a large eccen-
tric saccular coronary aneurysm (17mm× 9mm) at the proximal RCA. Intravascularultrasound;
Angioplasty
ultrasound (IVUS) showed absence of stent struts around the oriﬁce of aneurysm,
which suggested a fracture of SES stent. The entry of coronary aneurysm was ﬁnally
sealed with a polytetraﬂuoroethylene-covered stent. This report documented a rare
case of late giant coronary artery aneurysm associated with a fracture of SES.
© 2008 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights
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Introduction
Sirolimus eluting stents (SES) have dramatically
reduced the occurrence of angiographic and clini-
cal restenosis compared to bare-metal stents [1].
Despite this overall beneﬁt, clinical restenosis
occurs in up to 4—5% of unselected patients who
receive SES [2,3], and late stent thrombosis has
been reported to occur in about 1.0% of the patients
∗ Corresponding author.
E-mail address: tk-calf2@yamaguchi-u.ac.jp (T. Okamura).
(
c
r
a
o
0914-5087/$ — see front matter © 2008 Japanese College of Cardiolo
doi:10.1016/j.jjcc.2007.11.002reated with drug-eluting stents [3,4]. Recently, it
as been reported that stent fracture may be one of
he causes of in-stent restenosis or stent thrombosis
fter SES implantation [5—8]. Stent fracture of SES
s more likely to occur than that after bare-metal
tent implantation [9—11].
The formation of coronary artery aneurysm
CAA) is one of the critical complications after per-
utaneus coronary intervention (PCI). It has been
eported that after PCI, the aneurysm occurs with
frequency of 2—10% [12]. Recently, some cases
f development of CAA after implantation of a
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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(neurysm with stent fracture
rug-eluting stent have been reported [13—16].
owever, the main mechanism of CAA formation
fter drug-eluting stent is not yet clariﬁed. This
ase report described a rare case of late giant coro-
ary aneurysm which was probably associated with
fracture of SES.
ase report
73-year-old female with a history of hyperten-
ion, hypercholesterolemia and diabetes mellitus
nderwent coronary angiography (CAG), because of
table angina (CCS class III). She received an AAI
acemaker implantation due to sick sinus syndrome
en years ago. Her height was 157.5 cm, and weight
5 kg. Blood pressure was 110/60mmHg, pulse
0/min, regular. Blood chemistry showed total
holesterol was 188mg/dl, triglyceride 116mg/dl,
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igure 1 Angiograms of RCA on the ﬁrst admission. (A) Pr
arrow), and a diffuse severe stenosis could be seen in the p
een after pre-dilatation. (C) Post PCI. Three CypherTM stents
f RCA having some overlaps between stents. (D) Two weeks
istortion in geometry of the proximal stent during the hear
white arrow).75
igh-density lipoprotein cholesterol 31mg/dl, and
DL-C 134mg/dl, fasting blood sugar 124mg/dl,
bA1c 5.6% under the medication. Her coronary risk
actors were hypertension, hypercholesterolemia,
iabetes mellitus and obesity. In electrocardio-
ram, complete right bundle branch block and
bnormal Q waves with T wave inversions were
oticed in III, and precordial leads. An echocar-
iogram revealed left ventricular end-diastolic
imension was 58mm, ejection fraction 65% and
ild left ventricular hypertrophy. The inferior wall
f left ventricle showed normal contraction, but
ypokinesis of mid-septum and apex wall was
oticed. CAG revealed chronic total occlusion at
he middle portion of the right coronary artery
RCA) with a diffuse lesion proximal to the occluded
egment (Fig. 1A). A severe stenosis at the middle
ortion of the left anterior descending artery (LAD)
as also revealed. There were grade 3 collaterals
e PCI. RCA was totally occluded at the middle portion
roximal segment. (B) An arterial dissection (arrow) was
were deployed from the middle segment to the ostium
later after PCI. RCA angiography showed the pulsatile
t cycle (triangular arrow). There is a residual dissection
76 T. Okamura et al.
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nFigure 2 Angiograms of LCA on the ﬁrst admission. (A a
(triangular arrow) could be seen. (C and D) Immediately
stent (BMS) were deployed.
from the left circumﬂex artery (LCx) to RCA (Fig. 2A
and B).
An elective PCI for the RCA lesion was ﬁrst per-
formed. A 0.014-in. ﬂoppy guide wire and even
Miracle 3-gram guide wire (Asahi Intec Corp.) could
w
l
o
t
Figure 3 Angiograms of RCA at 8-months follow-up. (A and C)
segment of RCA (size: 17mm× 9mm). (B) Stent struts are se
PTFE-covered stent graft of 3.0mm× 14mm was implanted t) Pre PCI. A severe stenosis at the middle portion of LAD
r PCI. Two CypherTM stents (SES) and a Multi-Link ZetaTM
ot cross the lesion. A stiffer Miracle 6-g guide
ire (Asahi Intec Corp.) was then used to cross the
esion. After pre-dilatation using 2.0mm balloon
f this lesion, CAG revealed coronary dissection at
he proximal RCA (Fig. 1B). Three SESs (2.5/28mm,
A giant aneurysm formation was revealed at the proximal
parated at a distance of about 1 or 2mm (arrow). (D) A
o fully cover the aneurysm.
Aneurysm with stent fracture 77
Figure 4 IVUS images using a negative contrast injection at the site of the aneurysm. (A) Stent struts could be visible.
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wn aneurysm were revealed behind the struts (AN). (B) J
he wall of aneurysm did not provide a three-layer app
nternal elastic membrane.
.5/18mm and 3.0/18mm, CypherTM, Johnson &
ohnson, Miami, Florida, USA) were then deployed
rom the distal RCA to the RCA ostium with an
verlapping between each stents. Post-dilatation
as performed for all of the stents with a 3.0mm
on-compliant balloon up to 20 atm with a good
ngiographic result (Fig. 1C). Intravascular ultara-
ound (IVUS) was not performed then. Three weeks
ater, PCI was also provided in the LAD lesion. Two
ESs were deployed in LAD and one bare-metal stent
Multi-Link ZetaTM stent, Guidant Corp., USA.) were
sed for the bail-out situation to treat the distal-
dge dissection. Final angiography showed a good
ngiographic result (Fig. 2C and D). CAG of RCA at
he time revealed no in-stent restenosis but a pul-
atile deformation in geometry of the SES (Fig. 1D).
he had no angina after the intervention, and was
ischarged with an administration of 100mg aspirin
nd 200mg ticlopidine.
Eight months later after the PCIs, she was admit-
ed to our hospital with new angina. CAG revealed a
ocal and tight in-stent restenosis (90% stenosis) at
he site of bare-metal stent in the middle portion of
AD. CAG also revealed a large eccentric saccular
oronary aneurysm (17mm× 9mm) at the proximal
CA (Fig. 3A—C). The middle portion of LAD was
etreated with a balloon dilatation, which led to a
ood angiographic result. IVUS showed absence of
tent struts around the oriﬁce of aneurysm of RCA,
hich suggested a fracture of SES (Fig. 4). This seg-
ent was corresponded to a portion that showed
marked pulsatile deformation at the time of the
eployment of stent. Signiﬁcant in-stent neointimal
yperplasia could not be observed in any part of
he three SESs. It was suggested that the aneurysm
ight be a pseudoaneurysm without any thrombus
ormation, because IVUS did not show a three-layer
t
b
l
aroximal to the site of Fig. 4A. Stent struts were absent.
nce, suggesting that this was a pseudo-aneurysm. IEM:
ppearance of arterial wall. Considering the poten-
ial risk of coronary rupture, the entry of coronary
neurysm was ﬁnally sealed with a polytetraﬂuo-
oethylene (PTFE)-covered stent (Fig. 3D).
iscussion
his is the ﬁrst case report of a late giant coronary
neurysm associated with a fracture of sirolimus
luting stent, which was clearly depicted by both
AG and IVUS. Although the mechanism of aneurys-
al formation is still unclear, the stent fracture
ight be the main cause for this aneurysm through
plaque dissection (pseudoaneurysm) in this case.
The actual incidence of coronary arterial
neurysm (CAA) formation after SES implantation
s not yet thoroughly surveyed. Reported incidence
f CAA ranges from 3.9% to 5% after balloon angio-
lasty [17,18] and up to 10% after directional
oronary atherectomy [19]. According to the study
y Slota et al., the incidence of CAA was 3.9% in
he bare-metal stent group at 6-month angiographic
ollow-up and 7% in the balloon angioplasty group
20].
It has been described that the cause of new
AA formation after PCI may be an excessive use
f oversized balloons or high-pressure inﬂation of
he balloon resulting in intimal and medial tearing
ith continuous weakening and stretching of the
rtery [21—23]. These mechanical consequences
ay ﬁnally lead to the perforation of the media
ithout penetration of blood through the adventi-
ia. In this case, wall dissections were identiﬁed
oth RCA and LAD during each procedure. Both
esions were diffuse and calciﬁed. Immediately
fter SES deployment at the LAD, a minor dissection
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occurred at the distal edge of the stent probably
due to size mismatch with distal vessel size, which
was bailed out using the bare-metal stent. In con-
trast, a coronary dissection at the proximal RCA
after pre-dilatation might provide an initial trigger
of this aneurysmal formation. Post-dilatation with
high-pressure balloon inﬂations was used to opti-
mize the expansion of SESs, and then the dissection
was sealed off angiographically.
One of the remarkable features revealed in this
case was the SES fracture demonstrated by IVUS.
IVUS also showed absence of stent struts around
the aneurysm. It has been documented that stent
fracture may occur in 1.9—2.6% of cases with drug-
eluting stents, and that the in-stent restenosis at
the fractured lesion is up to 70% [6,7]. However,
the incidence of stent fracture may be underes-
timated, because not all of the stented patients
underwent the follow-up angiography and IVUS.
Sianos et al. [9] have described that in tortuous
vessels or calciﬁed lesions longer stents with a high
pressure are likely to be used, which then increase
the possibility of stent fracture. In this case, calci-
ﬁcation could be frequently observed around the
aneurysm. Repeated excessive movement at the
site of maximum bending of the stent might also
provoke stent fracture through extreme ﬂexion of
the vessel, excessive strut stretching, compres-
sion, torsion, kinking, elongation, and overloading
of shear stress [9,10,24]. Actually, the fracture in
this case occurred at the maximum bending and
ﬂexing site. It can be speculated that the edges of
fractured stent strut might injure the arterial wall.
Moreover, it is also possible that pulsatile stress
concentration to the dissected media might break
down the structure of arterial wall mechanically.
Another possible mechanism may be related to
the characteristic property of SES materials. SES
consists of three components that are stainless
steel metal, the polymer and the drug. Recently,
Gupta et al. reported two cases of CAA after SES
implantation, which needed a surgical repair [15].
The pathological ﬁndings in both cases showed an
inﬂammation at the site of aneurysm formation.
Virmani et al. reported that localized inﬂamma-
tion by polymer fragments of SES was speculated
as a cause of late stent thrombosis [25]. Inﬂam-
mations against the polymer may be one of the
causes of CAA formation after SES implantation.
On the other hand, anti-healing mechanism by the
eluted drugs might relate to CAA formation. Rab
et al. [26] reported CAA in 32% of patients who
received glucocorticoid following bailout stenting.
They suggested that steroid-mediated impairment
of vascular healing might have led to weakening of
the arterial wall and aneurysm formation. The inhi-T. Okamura et al.
ition of the healing process by silorimus, which
as anti-inﬂammatory properties, could have con-
ributed to the expansion of the weakened parts of
essel wall due to the trauma of PCI. Therefore,
rterial wall stress by the edge of fractured stent
trut coupled with an inﬂammatory response set
p by the polymer/drug combination, might have
educed the arterial wall tonus and developed CAA
15].
The long-term prognosis of balloon angioplasty
nduced CAA was as well as spontaneous CAA [17].
owever, the appropriate management of CAA after
ES implantation is unknown. The PCI using PTFE-
r autologous venous covered stent, the surgi-
al repair with CABG or conservative management
nder continuing dual-antiplatelet therapy were
onsiderable strategy. PTFE-covered stent might
e more convenient than autologous covered stent
12]. From any reasons, CAA can lead to serious
udden cardiovascular events such as thrombosis,
mbolization and rupture [27,28], which would be
atal. However, in this case, CAA was success-
ully sealed with PTFE-covered stent. Such types
f CAA which has a wide oriﬁce, a large branch
r a difﬁculty in stent delivery are not favor-
ble for treatment by covered stent. Although
upta et al. recommended that surgery should
e favored because hypersensitivity reaction to
he drug maybe persistent even after sealing the
neurysm [15], it was controversial. Alternatively,
f CAA is small and maybe has a lower risk for
upture, conservative management may be more
ppropriate. It is considered that multi-detector
ow computed tomography is useful in assessing the
ize of CAA. This case therefore might warn that the
atients stented with SESs should be meticulously
ollowed even if they are asymptomatic.
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